Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-004919
Filing Date
2017-02-07
Accepted
2017-02-07 16:57:07
Documents
1
Period of Report
2017-02-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3651
  Complete submission text file 0001140361-17-004919.txt   5333
Mailing Address 1775 38TH STREET BOULDER CO 80301
Business Address 1775 38TH STREET BOULDER CO 80301 303-545-5550
Bioptix, Inc. (Issuer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O VENAXIS, INC. 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address
Lundy Stephen T. (Reporting) CIK: 0001408113 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33675 | Film No.: 17579795